Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
GE HealthCare, a prominent player in the medical, precision and optical instruments industry, is headquartered in the United States. Founded in 1892, the company has evolved significantly, establishing itself as a leader in medical imaging, monitoring, and diagnostics. With a strong presence in North America, Europe, and Asia, GE HealthCare is renowned for its innovative technologies that enhance patient care and streamline healthcare operations.
The company offers a diverse range of core products and services, including advanced imaging systems, ultrasound equipment, and digital solutions that leverage artificial intelligence. These offerings are distinguished by their commitment to precision and reliability, making them essential tools for healthcare professionals worldwide. GE HealthCare's market position is bolstered by its continuous investment in research and development, leading to numerous accolades and recognition within the industry.
+61 vs industry average
GE HealthCare’s score of 93 is higher than 96% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medical Device Manufacturing has below-average carbon intensity
The Medical Device Manufacturing industry has reduced its overall emissions by 32% since 2018
Scope 3 accounts for ••• of total emissions.
GE HealthCare, a US-based medical, precision, and optical instruments company, has made significant commitments to address its carbon emissions.
In 2025, GE HealthCare's total reported emissions are projected to be approximately 4.9 billion kg CO2e. This includes about 103.86 million kg CO2e from Scope 1, approximately 97.7 million kg CO2e (market-based) or 181.98 million kg CO2e (location-based) from Scope 2, and an estimated 5.57 billion kg CO2e from Scope 3 emissions.
Looking back, the company's total emissions were approximately 5.9 billion kg CO2e in 2024, approximately 6.35 billion kg CO2e (Scope 3 only) plus 239 million kg CO2e (Scope 1 and 2 market-based) in 2023, approximately 7 billion kg CO2e in 2022, approximately 6.8 billion kg CO2e (Scope 3 only) plus 292 million kg CO2e (Scope 1 and 2 market-based) in 2021, and approximately 294.04 million kg CO2e (Scope 1 and 2 market-based) in 2020. Scope 3 data was not available for 2019 and 2020. In 2019, Scope 1 and 2 market-based emissions were approximately 329.46 million kg CO2e.
GE HealthCare is committed to achieving net-zero greenhouse gas emissions across its value chain by 2050. The company has near-term Science Based Targets initiative (SBTi) approved goals:
2030
42% reduction in Scope 2
GE Healthcare commits to reduce absolute scope 1 and 2 GHG emissions 42% by 2030 from a 2022 base year*. *The target boundary includes land-…
2030
25% reduction in scope 3 total
GE Healthcare also commits to reduce absolute scope 3 GHG emissions from purchased goods and services, upstream transportation and distribut…
2050
90% reduction in all scopes
GE Healthcare commits to reduce absolute scope 1, 2 and 3 GHG emissions 90% by 2050 from a 2022 base year*. *The target boundary includes la…
See all 5 climate goals
Already have an account? Sign in now
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
See all scope 3 categories
Already have an account? Sign in now


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Common questions about GE HealthCare’s sustainability data and climate commitments
Data year: 2025
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more